Analytical Data
-
Gene name
Calreticulin/CALR
- Application
-
Alternative Names
CRP55;Calregulin;Endoplasmic reticulum resident protein 60;ERp60;HACBP
-
Species
Cricetulus griseus
-
Source
Yeast
-
Tag
C- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8K3H7
-
Expression Region
18-417aa
-
Molecular Weight
48.1 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Calreticulin (CALR) is a multifunctional protein primarily located in the endoplasmic reticulum, playing crucial roles in calcium homeostasis, chaperone activity, and immune response modulation. The significance of CALR has escalated in recent years due to its association with various diseases, particularly myeloproliferative neoplasms (MPNs). Mutations in the CALR gene are found in a subset of patients with these disorders, contributing to abnormal cell proliferation and survival. Consequently, recombinant CALR proteins have gained attention for their potential in elucidating CALR's biological functions and the pathogenic mechanisms underlying CALR-mutated MPNs. Researchers are investigating the structural and functional properties of recombinant CALR, assessing its role in tumorigenesis and immune evasion, while also exploring its prospect as a therapeutic target. Understanding the dynamics of CALR and its variants provides vital insights into novel treatment strategies for CALR-related diseases, ultimately aiming for improved patient outcomes in hematologic malignancies.
